Home › Non-Hodgkin Lymphoma › Oregon › Portland

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Portland, OR

Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Portland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Nagre-recruitPhase 1/2

Oregon Health and Sciences University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06343311

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2

Providence Health & Services, Portland

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Oregon Health & Science University (OHSU), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Nagre-recruitPhase 2

Providence Portland Medical Center, Portland
Providence St. Vincent Medical Center, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Oregon Health & Science University, Portland

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Nagre-recruitObservasyonal na pag-aaral

Oregon Health and Science University Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Oregon Health and Science University Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Oregon Health & Science University/Doernbecher Children's Hospital, Portland

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

Providence Neurological Specialties West, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Kaiser Permanente Northwest, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Oregon Health and Science University - Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Nagre-recruitObservasyonal na pag-aaral

Local Institution - 0016, Portland

Lahat ng edad · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT06357754

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Portland

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

Oregon Health & Science University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Portland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.